6505-01-528-4028 ( NDC61314-0656-25 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-528-4028 | 6505 | 015284028 | CIPROFLOXACIN OPTHALMIC SOLUTION | 6757 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| FEAT | SPECIAL FEATURES | 0.3%, 2.5 ML BOTTLE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CIPROFLOXACIN OPHTHALMIC SOLUTION USP .3% 2.5 ML BT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.500 MILLILITERS |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC61314-0656-25 | 1VZL6 | A | 2 | 3 | 4 | ZZ |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC61314-0656-25 | 1VZL6 | FALCON PHARMACEUTICALS LTD | F | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 03/11/2 | P | 3004909185 | 6757 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DS | I | K | U/I CONTAINS 2 ML | ||
| DN | 9B----- | N | K | U/I CONTAINS 2 ML | |
| DA | C2201X- | A | K | U/I CONTAINS 2 ML | |
| DF | ------- | F | K | U/I CONTAINS 2 ML |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DA | SMS | L | 1 | BT | M | U | C2201X- | A | |
| DS | SMS | L | 1 | BT | M | U | D | ||
| DF | SMS | L | 1 | BT | M | U | ------- | F | |
| DN | SMS | L | 1 | BT | M | U | 9B----- | N |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|---|---|---|---|
| C | 2 | 2 | 01 | X |
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|